CoreFirst Bank & Trust
- SEC CIK
- 0001845199
- Latest filing
- Aug 5, 2026
MRK holding history
Merck & Co., Inc. in every 13F filed by CoreFirst Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRK overviewAll 13F holders of MRKFull Q2 2026 holdings
- Shares (Q2 2026)
- 8,877
- Value
- $1.14M
- % of portfolio
- 0.6%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,877 | $1.14M | 0.6% | −25−0.3% | Reduced | Holders |
| Q1 2026 | 8,902 | $1.07M | 0.6% | −697−7.3% | Reduced | Holders |
| Q4 2025 | 9,599 | $1.01M | 0.5% | −499−4.9% | Reduced | Holders |
| Q3 2025 | 10,098 | $847.5K | 0.5% | +185+1.9% | Added | Holders |
| Q2 2025 | 9,913 | $784.7K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 9,913 | $889.8K | 0.6% | −1,301−11.6% | Reduced | Holders |
| Q4 2024 | 11,214 | $1.12M | 0.7% | −381−3.3% | Reduced | Holders |
| Q3 2024 | 11,595 | $1.32M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 11,595 | $1.44M | 1.0% | −162−1.4% | Reduced | Holders |
| Q1 2024 | 11,757 | $1.55M | 1.0% | −507−4.1% | Reduced | Holders |
| Q4 2023 | 12,264 | $1.34M | 0.9% | −265−2.1% | Reduced | Holders |
| Q3 2023 | 12,529 | $1.29M | 0.9% | −23−0.2% | Reduced | Holders |
| Q2 2023 | 12,552 | $1.45M | 1.0% | −841−6.3% | Reduced | Holders |
| Q1 2023 | 13,393 | $1.42M | 1.0% | −934−6.5% | Reduced | Holders |
| Q4 2022 | 14,327 | $1.59M | 1.2% | −36−0.3% | Reduced | Holders |
| Q3 2022 | 14,363 | $1.24M | 1.1% | −482−3.2% | Reduced | Holders |
| Q2 2022 | 14,845 | $1.35M | 1.1% | +1,024+7.4% | Added | Holders |
| Q1 2022 | 13,821 | $1.13M | 0.8% | −620−4.3% | Reduced | Holders |
| Q4 2021 | 14,441 | $1.11M | 0.7% | −190−1.3% | Reduced | Holders |
| Q3 2021 | 14,631 | $1.10M | 0.8% | +705+5.1% | Added | Holders |
| Q2 2021 | 13,926 | $1.08M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2021 | 13,926 | $1.07M | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.